Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Weizmann institute scientists solve the 3-D structure of the enzyme involved in Gaucher disease

02.06.2003


Glucocerebrosidase


Discovery may help design effective therapies for the genetic disease that mainly affects Ashkenazi Jews

An interdisciplinary team of Weizmann Institute scientists has solved the three-dimensional structure of an enzyme called glucocerebrosidase. Mutations occurring in this enzyme cause Gaucher disease, a genetic illness that mainly affects Ashkenazi Jews. The Institute study, published recently in EMBO Reports, may lead to the design of effective new therapies for treating the disease.

Gaucher disease was first described in 1882 by the French physician Philippe Gaucher. It is characterized by swelling and enlargement of the spleen and liver and disruption in the function of these organs, and in rare cases it also affects the brain. In the 1920s, the disease was found to be caused by the excessive accumulation of a fatty substance, or lipid, called glucosylceramide. In the 1960s, researchers discovered that the accumulation occurs due to a defect in the glucocerebrosidase enzyme, whose function is to break down this lipid and regulate its amount. In the 1980s, the gene responsible for manufacturing the enzyme was isolated; scientists found that mutations in this gene disrupt the function of the enzyme, leading to the development of Gaucher disease.



By the early 1990s, the U.S. company Genzyme started producing the enzyme – first from placenta, then by genetic engineering. Today thousands of Gaucher patients are treated by injections of the enzyme, an approach called enzyme replacement therapy, or ERT. The annual cost of the therapy per patient is approximately $100,000 to $300,000. Obviously, more affordable alternatives, such as the ones that may emerge from the Weizmann Institute study, are urgently needed.

The Institute team included Prof. Tony Futerman of the Biological Chemistry Department, Prof. Joel Sussman of the Structural Biology Department and Prof. Israel Silman of the Neurobiology Department, as well as Dr. Michal Harel, Lilly Toker and graduate student Hay Dvir.

The first step in solving the three-dimensional structure of an enzyme is to grow its crystals. In the case of the glucocerebrosidase enzyme involved in Gaucher disease, the crystallization was a formidable challenge. The Weizmann Institute scientists succeeded in this task by cutting parts of certain sugar molecules on the surface of the enzyme.

The scientists then resorted to X-ray crystallography, a method in which the crystal is exposed to X-rays and the structure of its molecules is determined by the diffraction pattern of the X-rays. The X-ray data were collected at the European Synchrotron Radiation Facility in Grenoble, France.

The solution of the enzyme structure may lead to the development of new therapies for Gaucher disease. First, the structural information may help design a more effective enzyme that will improve today’s ERT therapy. This approach is most likely to provide effective additional treatments for Gaucher disease, until the development of gene therapy for this disorder is developed. Another type of therapy likely to emerge from the Weizmann findings is the design of small molecules that will supplement the damaged enzyme in the patient’s body, thereby restoring its normal functioning.

Yeda Research and Development Co., which is responsible for the commercialization of Weizmann Institute research, has filed a patent application for the medical applications of these findings.

Prof. Futerman’s research is supported by The Estate of Ernst and Anni Deutsch-Promotor Stiftung, Switzerland, Paul Godfrey Foundation, and Buddy Taub Foundation. Prof. Futerman is the incumbent of the Joseph Meyerhoff Professorial Chair of Biochemistry.

Prof. Sussman’s research is supported by the Charles A. Dana Foundation, Jean and Jula Goldwurm Memorial Foundation, Helen & Milton A. Kimmelman Center for Biomolecular Structure & Assembly, Joseph and Ceil Mazer Center for Structural Biology, and The late Sally Schnitzer. Prof. Joel Sussman is the incumbent of the Morton and Gladys Pickman Chair in Structural Biology.

Prof. Israel Silman’s research is supported by Nella and Leon Benoziyo Center for Neurosciences, Charles A. Dana Foundation, Carl and Micaela Einhorn-Dominic Brain Research Institute, Helen & Milton A. Kimmelman Center for Biomolecular Structure & Assembly. Prof. Silman is the incumbent of the Bernstein-Mason Professorial Chair of Neurochemistry.


The Weizmann Institute of Science in Rehovot, Israel, is one of the world’s top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to 2,500 scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.

Alex Smith | EurekAlert!
Further information:
http://www.weizmann.ac.il/

More articles from Interdisciplinary Research:

nachricht Bergamotene - alluring and lethal for Manduca sexta
21.04.2017 | Max-Planck-Institut für chemische Ökologie

nachricht How to color a lizard: From biology to mathematics
13.04.2017 | Université de Genève

All articles from Interdisciplinary Research >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Touch Displays WAY-AX and WAY-DX by WayCon

27.06.2017 | Power and Electrical Engineering

Drones that drive

27.06.2017 | Information Technology

Ultra-compact phase modulators based on graphene plasmons

27.06.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>